Treatment diary for botulinum toxin spasticity treatment: a pilot study
Research output: Contribution to journal › Letter › Research › peer-review
Standard
Treatment diary for botulinum toxin spasticity treatment : a pilot study. / Biering-Sørensen, Bo; Iversen, Helle K; Frederiksen, Inge M S; Vilhelmsen, Jeanet R; Biering-Sørensen, Fin.
In: International Journal of Rehabilitation Research, Vol. 40, No. 2, 2017, p. 175-184.Research output: Contribution to journal › Letter › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Treatment diary for botulinum toxin spasticity treatment
T2 - a pilot study
AU - Biering-Sørensen, Bo
AU - Iversen, Helle K
AU - Frederiksen, Inge M S
AU - Vilhelmsen, Jeanet R
AU - Biering-Sørensen, Fin
PY - 2017
Y1 - 2017
N2 - The aim of this study is to develop a treatment diary for patients receiving spasticity treatment including botulinum toxin injection and physiotherapy and/or occupational therapy. The diary focuses on problems triggered by skeletal muscle overactivity; agreed goals for treatment and the patient's self-evaluation of achievement on the Goal Attainment Scale; which skeletal muscles were injected; physiotherapists' and occupational therapists' evaluation of the patients' achievement of objectives on the Goal Attainment Scale; and proposals for optimization of treatment and changing goals. The evaluation included a satisfaction questionnaire and the WHO-QoL BREF and WHO-5 well-being score. Overall, 10 patients were enrolled in the pilot study. The patients were generally satisfied with the diary, found that it involved them more in their treatment and made it easier to set personal goals, and found it worth the time spent using it. However, no clear advantage in relation to their quality of life (WHO-QoL BREF and WHO-5 well-being score) was reported.
AB - The aim of this study is to develop a treatment diary for patients receiving spasticity treatment including botulinum toxin injection and physiotherapy and/or occupational therapy. The diary focuses on problems triggered by skeletal muscle overactivity; agreed goals for treatment and the patient's self-evaluation of achievement on the Goal Attainment Scale; which skeletal muscles were injected; physiotherapists' and occupational therapists' evaluation of the patients' achievement of objectives on the Goal Attainment Scale; and proposals for optimization of treatment and changing goals. The evaluation included a satisfaction questionnaire and the WHO-QoL BREF and WHO-5 well-being score. Overall, 10 patients were enrolled in the pilot study. The patients were generally satisfied with the diary, found that it involved them more in their treatment and made it easier to set personal goals, and found it worth the time spent using it. However, no clear advantage in relation to their quality of life (WHO-QoL BREF and WHO-5 well-being score) was reported.
KW - Adult
KW - Botulinum Toxins/therapeutic use
KW - Female
KW - Goals
KW - Humans
KW - Male
KW - Middle Aged
KW - Muscle Spasticity/therapy
KW - Neuromuscular Agents/therapeutic use
KW - Occupational Therapy
KW - Physical Therapy Modalities
KW - Pilot Projects
KW - Quality of Life
KW - Records as Topic
KW - Self Report
U2 - 10.1097/MRR.0000000000000221
DO - 10.1097/MRR.0000000000000221
M3 - Letter
C2 - 28225535
VL - 40
SP - 175
EP - 184
JO - International Journal of Rehabilitation Research
JF - International Journal of Rehabilitation Research
SN - 0342-5282
IS - 2
ER -
ID: 194039868